891494-63-6Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1GMIZZEXBPRLVIV-SECBINFHSA-NSch 900776 has been used in trials studying the treatment of Neoplasms, Hodgkin Disease, Adult Erythroleukemia, Lymphoma, Non-Hodgkin, and Myelogenous Leukemia, Acute, among others.
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
UsesThis compound acts as a novel Chk1 inhibitor acting as an anticancer agent.
Loading…
Loading…
No reaction records under the current filter.
Loading…
891494-63-6DTXSID00237551CHEMBL2386889